← Mechanisms of action
Opioid receptors; mu/kappa/delta
PROTEIN FAMILYHomo sapiens
Linked proteins
Drugs acting on this target (11)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| benzhydrocodone (Apadaz) | Agonist | approved | Small molecule | Opioid receptors; mu/kappa/delta agonist |
| cebranopadol | Agonist | experimental | Small molecule | Opioid receptors; mu/kappa/delta agonist |
| codeine (Phenergan) | Agonist | approved | Small molecule | Opioid receptors; mu/kappa/delta agonist |
| hydrocodone (hycodan) | Agonist | approved | Small molecule | Opioid receptors; mu/kappa/delta agonist |
| nalbuphine (nubain) | Agonist | approved | Small molecule | Opioid receptors; mu/kappa/delta agonist |
| oxymorphone (opana) | Agonist | approved | Small molecule | Opioid receptors; mu/kappa/delta agonist |
| pyrrolamidolum | Agonist | experimental | Small molecule | Opioid receptors; mu/kappa/delta agonist |
| nalmefene (revex) | Antagonist | approved | Small molecule | Opioid receptors; mu/kappa/delta antagonist |
| naloxone (narcan) | Antagonist | approved | Small molecule | Opioid receptors; mu/kappa/delta antagonist |
| naltrexone (revia) | Antagonist | approved | Small molecule | Opioid receptors; mu/kappa/delta antagonist |
| ondelopran | Antagonist | experimental | Small molecule | Opioid receptors; mu/kappa/delta antagonist |